Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells Exosomes for the Treatment of Trigeminal Neuralgia
Latest Information Update: 22 Apr 2025
At a glance
- Drugs Umbilical cord-derived allogeneic mesenchymal stem cell therapy-Vitro Biopharma (Primary)
- Indications Peripheral neuropathies; Trigeminal neuralgia
- Focus Adverse reactions
Most Recent Events
- 06 Jan 2022 New trial record